Secondary pulmonary hypertension [dsyn]
Arterial [bpoc]
treated [topp]
Endothelin [aapp, bacs]
receptor [aapp, rcpt]
Blockade [ftcn]
Secondary pulmonary hypertension [dsyn]
Arterial [bpoc]
Variety [cnce]
Systemic Disorder [dsyn]
collagen vascular diseases [dsyn]
chronic [tmco]
Thromboembolism [dsyn]
Virus, Human Immunodeficiency [virs]
Portopulmonary hypertension [dsyn]
Diseases [dsyn]
progression [patf]
Secondary pulmonary hypertension [dsyn]
Arterial [bpoc]
Stabilisation [topp]
Contributing [acty]
Quality [qlco]
Life [idcn]
Unfavorable [qlco]
Survival [acty]
Patients [podg]
treatment [ftcn]
Oxygen [elii, phsu]
Supplementation [topp]
symptoms [ftcn]
Specific [qlco]
therapy [ftcn]
Secondary pulmonary hypertension [dsyn]
Arterial [bpoc]
Currently [tmco]
Exist [cnce]
Endothelin Receptor [aapp, rcpt]
Blockade [ftcn]
bosentan [orch, phsu]
treatment [ftcn]
Primary pulmonary hypertension [dsyn]
Efficacy [qlco]
therapy [ftcn]
Secondary pulmonary hypertension [dsyn]
Arterial [bpoc]
Established [qlco]
Case Series [resa]
Patients [podg]
Secondary pulmonary hypertension [dsyn]
Arterial [bpoc]
Benefit [qnco]
Endothelin Receptor [aapp, rcpt]
Blockade [ftcn]
therapy [ftcn]
Secondary pulmonary hypertension [dsyn]
Arterial [bpoc]
included [ftcn]
Collagen (vascular) disease NOS [dsyn]
Scleroderma [dsyn]
Lupus Erythematosus, Systemic [dsyn]
Chronic disease [dsyn]
thromboembolic [ftcn]
granulomatous vasculitis [dsyn]
Sarcoidosis [dsyn]
therapy [ftcn]
bosentan [orch, phsu]
LED [mnob]
Improvement [cnce]
symptoms [ftcn]
New York Heart Association Class [fndg]
Functional [ftcn]
Walking distance [fndg]
Patients [podg]
Distance [qnco]
Walk [dora]
minute [tmco]
Increased [qnco]
M NOS [aapp, imft]
baseline [bodm]
M NOS [aapp, imft]
Average [qnco]
months [tmco]
bosentan [orch, phsu]
treatment [ftcn]
pulmonary arterial pressure [diap]
Decreased [qnco]
Patients [podg]
Echocardiography [diap]
Case Series [resa]
Suggest [idcn]
Endothelin Receptor [aapp, rcpt]
Blockade [ftcn]
therapy [ftcn]
Secondary pulmonary hypertension [dsyn]
Arterial [bpoc]
Interest [menp]
Pharmacologic Management [hlca]
Secondary pulmonary hypertension [dsyn]
Arterial [bpoc]
prospective [resa]
Controlled Clinical Trial [inpr]
bosentan [orch, phsu]
Secondary pulmonary hypertension [dsyn]
Arterial [bpoc]
Needed [qlco]
